Q1 2019 Holdings
Filed 2019-05-14 | 16 holdings | $40.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $24.9M | 3,061,091 | 61.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $15.2M | 1,068,044 | 37.8% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $27.8K | 970,630 | 0.1% |
| Tricida Inc(1T7) | COM | 89610F101 | $25.1K | 650,585 | 0.1% |
| Obseva SA | COM | H5861P103 | $14.8K | 1,159,789 | 0.0% |
| Orchard RX Ltd | COM | 68570P101 | $14.5K | 811,030 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $13.3K | 594,713 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $10.2K | 809,323 | 0.0% |
| La Jolla Pharmaceuticals(LJPC) | COM | 503459604 | $6.5K | 1,003,600 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | $5.9K | 327,777 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $5.3K | 1,258,964 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $3.7K | 1,387,874 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $1.6K | 2,417,227 | 0.0% |
| Gemphire Therapeutics | COM | 36870A108 | $1.0K | 869,538 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $911 | 722,890 | 0.0% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $903 | 66,667 | 0.0% |